Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Cardiovascular Radiology: Page 212
Dual-source CTA improves temporal resolution for cardiac imaging
By
Radiology Review
(Radiology Review) Dual-source CT angiography (CTA) enables noninvasive, functional cardiac analysis, including accurate assessment of left ventricular myocardial function and reliable evaluation of regional wall motion, according to a pilot study by German researchers.
December 27, 2007
Toshiba basks in Aquilion One glow, but more work remains
By
Brian Casey
It was one of the bigger RSNA marketing coups in recent memory: Toshiba America Medical Systems debuted its Aquilion One 320-slice CT scanner at the RSNA 2007 show, catching many attendees by surprise. But the launch of Aquilion One has raised as many questions as it answered.
December 23, 2007
BG Medicine helps to launch plaque study
By
AuntMinnie.com staff writers
Life sciences firm BG Medicine of Waltham, MA, has launched a new clinical study with a group of corporate partners intended to catch coronary artery disease before it attacks, the company said.
December 20, 2007
GE to sell Draxis generic MIBI
By
AuntMinnie.com staff writers
Canadian radiopharmaceutical developer Draxis Health of Mississauga, Ontario, has signed a deal with GE Healthcare giving the Chalfont St. Giles, U.K.-based company rights to sell Draxis generic technetium-99m sestamibi in the U.S.
December 20, 2007
MediGuide Medical GPS gets CE Mark
By
AuntMinnie.com staff writers
MediGuide of Haifa, Israel, has received European CE Mark certification for its Medical Position System (MPS) and MPS-enabled Guided Measurement Catheter (GMC).
December 17, 2007
Volcano to buy CardioSpectra
By
AuntMinnie.com staff writers
With an eye on broadening its presence in the interventional medicine market, intravascular ultrasound developer Volcano has signed an agreement to acquire optical coherence tomography (OCT) developer CardioSpectra of San Antonio for $25 million in cash.
December 12, 2007
CTA predicts mortality, shows variable risk per vessel
By
Eric Barnes
Two major cautionary notes attached to coronary CT angiography (CTA) are the scarcity of literature proving a benefit in patients at risk of coronary artery disease (CAD) and its high radiation dose. Researchers at UCLA-Harbor Medical Center in Torrance, CA, believe they've gone a long way toward conquering both limitations with a low-dose 64-slice CT exam protocol and participation in several new studies suggesting a high prognostic value for CTA studies.
December 6, 2007
Toshiba, TomTec to partner on cardiac 4D ultrasound
By
AuntMinnie.com staff writers
Toshiba Medical Systems of Tokyo has inked an agreement with TomTec Imaging Systems of Munich to produce tools for assessing cardiac 4D data, the company announced.
December 5, 2007
Bristol-Myers Squibb to divest imaging unit, including Cardiolite radiopharmaceutical
By
Brian Casey
Pharmaceutical giant Bristol-Myers Squibb is planning to sell off its medical imaging unit as part of a restructuring of the New York City-based company. The firm's medical imaging division markets the Cardiolite technetium-based radiopharmaceutical, as well as other radiopharmaceuticals and ultrasound contrast media.
December 4, 2007
DSCT matches angiography for stenosis detection -- even in fast hearts
By
Jerry Ingram
Dual-source CT (DSCT) offers diagnostic accuracy comparable to that of invasive coronary angiography when it comes to identifying significant coronary artery stenoses, according to researchers from Germany. To test whether DSCT could match angiography in accuracy, they examined patients with suspected coronary artery disease and found DSCT angiography offered high sensitivity for detecting stenosis.
December 3, 2007
AuntMinnie.com Cardiac Imaging Insider
By
Eric Barnes
December 2, 2007
Medtronic completes PMA filing for Talent
By
AuntMinnie.com staff writers
Interventional technology firm Medtronic has filed the final module of its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its Talent abdominal stent graft system.
December 2, 2007
Previous Page
Page 212 of 328
Next Page